Product Name:2-Chloro-4-(1H-Pyrazol-5-Yl)Benzonitrile

IUPAC Name:2-chloro-4-(1H-pyrazol-5-yl)benzonitrile

CAS:1297537-37-1
Molecular Formula:C10H6ClN3
Purity:98%
Catalog Number:CM336286
Molecular Weight:203.63

Packing Unit Available Stock Price($) Quantity
CM336286-1g in stock Ⱥǜ
CM336286-5g in stock ȡȐȺ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:1297537-37-1
Molecular Formula:C10H6ClN3
Melting Point:-
Smiles Code:N#CC1=CC=C(C2=CC=NN2)C=C1Cl
Density:
Catalog Number:CM336286
Molecular Weight:203.63
Boiling Point:
MDL No:
Storage:Keep in a tight container and store at ambient temperature

Category Infos

Pyrazoles
Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
Pyrazone
Custom pyrazone for customers from all over the world are our main business.
New
Custom Organic Synthesis,Where to Buy Chemical Building Blocks - Chemenu
Pharmaceutical intermediates, bulk products, chiral, achiral, heterocycles, metal catalysts, amino acids, peptides, benzene, pyridine, pyrazine, triazine, piperidine, piperazine, morpholine, imidazoline, cyclopropane, indole, benzotriazole, anthranil, quinoline, naphthalene, boronic compounds, fluorination, oxidation, rearrangement reaction
Chemenu product lines cover amino acids and peptides, heterocyclic compounds, alkanes and aromatic compounds, carbohydrates, alcohols, aldehydes & ketones, pyridazines, metal catalysts and other pharmaceutical intermediates. For more custom organic synthesis, please contact us for a quote.

Column Infos

Darolutamide
Bayer announced that its Phase 3 clinical ARANOTE trial met its primary endpoint. Its oral androgen receptor inhibitor (ARi) NUBEQA® (darolutamide) combined with androgen deprivation therapy (ADT) significantly improved radiographic progression-free survival (rPFS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). NUBEQA® (darolutamide) is an oral androgen receptor inhibitor with a distinct chemical structure that binds to androgen receptors with high affinity and exhibits strong antagonistic activity, thereby inhibiting receptor function and the growth of prostate cancer cells.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products